145 related articles for article (PubMed ID: 12899722)
41. Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase. A novel bifunctional enzyme in malaria parasites.
Clarke JL; Scopes DA; Sodeinde O; Mason PJ
Eur J Biochem; 2001 Apr; 268(7):2013-9. PubMed ID: 11277923
[TBL] [Abstract][Full Text] [Related]
42. Fused Enzyme Glucose-6-Phosphate Dehydrogenase::6-Phosphogluconolactonase (G6PD::6PGL) as a Potential Drug Target in
Morales-Luna L; Vázquez-Bautista M; Martínez-Rosas V; Rojas-Alarcón MA; Ortega-Cuellar D; González-Valdez A; Pérez de la Cruz V; Arreguin-Espinosa R; Rodríguez-Bustamante E; Rodríguez-Flores E; Hernández-Ochoa B; Gómez-Manzo S
Microorganisms; 2024 Jan; 12(1):. PubMed ID: 38257939
[TBL] [Abstract][Full Text] [Related]
43. Frequency of G6PD Mediterranean in individuals with and without malaria in Southern Pakistan.
Moiz B; Arshad HM; Raheem A; Hayat H; Karim Ghanchi N; Beg MA
Malar J; 2017 Oct; 16(1):426. PubMed ID: 29065882
[TBL] [Abstract][Full Text] [Related]
44. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
Malar J; 2015 May; 14():218. PubMed ID: 26017006
[TBL] [Abstract][Full Text] [Related]
45. Biochemical and cytochemical evaluation of heterozygote individuals with glucose-6-phosphate dehydrogenase deficiency.
Gurbuz N; Aksu TA; Van Noorden CJ
Acta Histochem; 2005; 107(4):261-7. PubMed ID: 16139339
[TBL] [Abstract][Full Text] [Related]
46. G6PD A- deficiency and severe malaria in The Gambia: heterozygote advantage and possible homozygote disadvantage.
Sirugo G; Predazzi IM; Bartlett J; Tacconelli A; Walther M; Williams SM
Am J Trop Med Hyg; 2014 May; 90(5):856-9. PubMed ID: 24615128
[TBL] [Abstract][Full Text] [Related]
47. About hemoglobins, G6PD and parasites in red cells.
Luzzatto L
Experientia; 1995 Mar; 51(3):206-8. PubMed ID: 7698279
[No Abstract] [Full Text] [Related]
48. Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.
Nguetse CN; Meyer CG; Adegnika AA; Agbenyega T; Ogutu BR; Kremsner PG; Velavan TP
Malar J; 2016 Jul; 15(1):346. PubMed ID: 27388012
[TBL] [Abstract][Full Text] [Related]
49. [Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S; Pradines B; Basco LK
Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
[TBL] [Abstract][Full Text] [Related]
50. Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target.
Allen SM; Lim EE; Jortzik E; Preuss J; Chua HH; MacRae JI; Rahlfs S; Haeussler K; Downton MT; McConville MJ; Becker K; Ralph SA
FEBS J; 2015 Oct; 282(19):3808-23. PubMed ID: 26198663
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of a flow cytometric test for G6PD-deficient erythrocytes.
Kapadia AB; Sharma P; Jain K; Sachdeva MUS; Bose PL; Gupta M; Khadwal AR; Bal A; Das R; Varma N
Trop Med Int Health; 2021 Apr; 26(4):462-468. PubMed ID: 33415798
[TBL] [Abstract][Full Text] [Related]
52. Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.
Tsegaye A; Golassa L; Mamo H; Erko B
Malar J; 2014 Nov; 13():438. PubMed ID: 25406667
[TBL] [Abstract][Full Text] [Related]
53. Cloning of the glucose 6-phosphate dehydrogenase gene from Plasmodium falciparum.
O'Brien E; Kurdi-Haidar B; Wanachiwanawin W; Carvajal JL; Vulliamy TJ; Cappadoro M; Mason PJ; Luzzatto L
Mol Biochem Parasitol; 1994 Apr; 64(2):313-26. PubMed ID: 7935609
[TBL] [Abstract][Full Text] [Related]
54. Glucose-6-phosphate dehydrogenase deficiency and malaria.
Ruwende C; Hill A
J Mol Med (Berl); 1998 Jul; 76(8):581-8. PubMed ID: 9694435
[TBL] [Abstract][Full Text] [Related]
55. Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites.
Luzzatto L; Usanga FA; Reddy S
Science; 1969 May; 164(3881):839-42. PubMed ID: 4889647
[TBL] [Abstract][Full Text] [Related]
56. Stress response and cytoskeletal proteins involved in erythrocyte membrane remodeling upon Plasmodium falciparum invasion are differentially carbonylated in G6PD A- deficiency.
Méndez D; Linares M; Diez A; Puyet A; Bautista JM
Free Radic Biol Med; 2011 May; 50(10):1305-13. PubMed ID: 21376116
[TBL] [Abstract][Full Text] [Related]
57. The effect of purified aminoaldehydes produced by polyamine oxidation on the development in vitro of Plasmodium falciparum in normal and glucose-6-phosphate-dehydrogenase-deficient erythrocytes.
Morgan DM; Bachrach U; Assaraf YG; Harari E; Golenser J
Biochem J; 1986 May; 236(1):97-101. PubMed ID: 3539102
[TBL] [Abstract][Full Text] [Related]
58. Malaria and erythrocyte glucose-6-phosphate dehydrogenase variants in West Africa.
Bienzle U; Guggenmoos-Holzmann I; Luzzatto L
Am J Trop Med Hyg; 1979 Jul; 28(4):619-21. PubMed ID: 464185
[TBL] [Abstract][Full Text] [Related]
59. Antibody responses to P. falciparum Apical Membrane Antigen 1(AMA-1) in relation to haemoglobin S (HbS), HbC, G6PD and ABO blood groups among Fulani and Masaleit living in Western Sudan.
Nasr A; Saleh AM; Eltoum M; Abushouk A; Hamza A; Aljada A; El-Toum ME; Abu-Zeid YA; Allam G; ElGhazali G
Acta Trop; 2018 Jun; 182():115-123. PubMed ID: 29486174
[TBL] [Abstract][Full Text] [Related]
60. Alternations in quantities and activities of erythrocyte cytosolic carbonic anhydrase isoenzymes in glucose-6-phosphate dehydrogenase-deficient individuals.
Chiang WL; Chu SC; Lai JC; Yang SF; Chiou HL; Hsieh YS
Clin Chim Acta; 2001 Dec; 314(1-2):195-201. PubMed ID: 11718695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
